Queen Mary University of London

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search

Queen Mary University of London (or QMUL) is a university in London, England, UK. Its main campus is in Mile End in East London.[1] The university was the home of the principal investigator of the PACE trial, Peter White.

ME/CFS Research[edit | edit source]

Professor Peter White was principle investigator for the controversial PACE trial, and first author of the main PACE trial outcome study. QMUL spent approximately £250,000 unsuccessfully attempting to prevent the release of anonymized PACE trial data under the Freedom of Information Act law.

Wolfson Institute for Preventative Medicine[edit | edit source]

The Wolfson Institute for Preventative Medicine consists of Queen Mary University's Institute of Psychiatry plus two other research departments.[2] After the PACE trial research was completed, the Wolfson Institute removed the majority of the PACE trial documentation, although some remains.

Online presence[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. "Queen Mary University of London". www.qmul.ac.uk. Retrieved Feb 21, 2019. 
  2. "About the Wolfson Institute - Wolfson Institute of Preventive Medicine - Barts and The London". www.qmul.ac.uk. Retrieved Feb 21, 2019. 

PACE trial - A controversial study which claimed that CBT and GET were effective in treating "CFS/ME", despite the fact that its own data did not support this conclusion. Its results and methodology were widely disputed by patients, scientists, and the peer-reviewed scientific literature.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.